3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
3
Rectal Neoplasms
2
Neoplasms
2
Glioma
2
Glioblastoma
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma
1
Radiation Injuries
1
Prostatic Neoplasms
1
Postoperative Complications
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Melanoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Low Anterior Resection Syndrome
1
Liposarcoma
1
Leiomyosarcoma
1
Hepatic Veno-Occlusive Disease
1
Head and Neck Neoplasms
1
Fatigue
1
Interventions
Cisplatin
12
Gemcitabine
9
Specimen Handling
6
Radiotherapy, Intensity-Modulated
6
Magnetic Resonance Spectroscopy
6
Drug Therapy
5
toripalimab
4
Platinum
4
Nivolumab
4
Capecitabine
4
1,2-diaminocyclohexaneplatinum II citrate
4
spartalizumab
3
Radiotherapy
3
Immune Checkpoint Inhibitors
3
sintilimab
2
Ipilimumab
2
Immunoglobulin G
2
Docetaxel
2
Disulfides
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
tislelizumab
1
relatlimab
1
pembrolizumab
1
olaparib
1
fluciclovine F-18
1
dehydroftorafur
1
cemiplimab
1
camrelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
Surgical Procedures, Operative
×
30 days
×
Clear all
No trials found.